Skip to content

Understanding schizophrenia medication usage

Prescribing patterns of psychotropics in patients with schizophrenia: An observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/06/069065
Enrollment
154
Registered
2024-06-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F20- Schizophrenia

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Pt.B.D. Sharma UHS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All patients who are â?¥ 18 years of age and are diagnosed with schizophrenia. 2.Male or female patients fulfilling DSM-5 criteria of schizophrenia. 3.Patients who are willing to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1.History of any chronic physical or any other psychiatric illness. 2.Pregnant and lactating mothers. 3.Patients with psychoactive substance use disorder other than tobacco use.

Design outcomes

Primary

MeasureTime frame
Drug prescriptions will be analyzed by WHO/INRUD and 2 other drug prescription indicators during the visits.Timepoint: 1.WHO/INRUD drug prescription indicators 2.Percentage of prescriptions containing fixed-dose combinations. 3.Percentage of polypharmacy (prescribing 4 or more drugs of disease that require long-term treatment. Nutritional supplements, other vitamins and electrolytes will be excluded.)

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Shubham Chaudhari

Pt.B.D Sharma. PGIMS, Rohtak

chaudharishubham921@gmail.com9321524815

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026